File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Evidence-based review of surgical practices in endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction and other new indications

TitleEvidence-based review of surgical practices in endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction and other new indications
Authors
Issue Date2014
Citation
Curr Opin Ophthalmol, 2014, v. 25 n. 5, p. 443-8 How to Cite?
AbstractPURPOSE OF REVIEW: To review the current surgical practices in endoscopic endonasal dacryocystorhinostomy (EN-DCR) from the studies of last 12 months. RECENT FINDINGS: Success rates in EN-DCR now rival those of the conventional external approach. Indications are expanding beyond primary acquired nasolacrimal duct obstruction to include DCR revisions, acute lacrimal sac abscesses, nasolacrimal duct obstructions in patients who have received chemotherapy or radiation, and common canalicular obstructions. There is limited evidence that intubation with silicone stents improves the outcomes. Mitomycin C appears to improve the success rates of EN-DCR, especially revision surgery. Concomitant procedures, such as septoplasty and anterior middle turbinectomy, are sometimes required in primary as well as revision EN-DCR to achieve high success rates. There is increasing evidence that silicone stents are of limited benefit, whereas mucosal flap formation has been of benefit in case series. SUMMARY: With innovations and improvements in the endonasal approach, EN-DCR has become a viable alternative to external DCR for primary acquired nasolacrimal duct obstruction. EN-DCR has the distinct advantages of no surface scar and a lack of damage to the pump mechanism that often occur with external DCR. Recent evidence indicates a comparable success rate to external DCR.
Persistent Identifierhttp://hdl.handle.net/10722/205566
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMarcet, MMen_US
dc.contributor.authorKuk, AKen_US
dc.contributor.authorPhelps, POen_US
dc.date.accessioned2014-09-20T04:00:21Z-
dc.date.available2014-09-20T04:00:21Z-
dc.date.issued2014en_US
dc.identifier.citationCurr Opin Ophthalmol, 2014, v. 25 n. 5, p. 443-8en_US
dc.identifier.urihttp://hdl.handle.net/10722/205566-
dc.description.abstractPURPOSE OF REVIEW: To review the current surgical practices in endoscopic endonasal dacryocystorhinostomy (EN-DCR) from the studies of last 12 months. RECENT FINDINGS: Success rates in EN-DCR now rival those of the conventional external approach. Indications are expanding beyond primary acquired nasolacrimal duct obstruction to include DCR revisions, acute lacrimal sac abscesses, nasolacrimal duct obstructions in patients who have received chemotherapy or radiation, and common canalicular obstructions. There is limited evidence that intubation with silicone stents improves the outcomes. Mitomycin C appears to improve the success rates of EN-DCR, especially revision surgery. Concomitant procedures, such as septoplasty and anterior middle turbinectomy, are sometimes required in primary as well as revision EN-DCR to achieve high success rates. There is increasing evidence that silicone stents are of limited benefit, whereas mucosal flap formation has been of benefit in case series. SUMMARY: With innovations and improvements in the endonasal approach, EN-DCR has become a viable alternative to external DCR for primary acquired nasolacrimal duct obstruction. EN-DCR has the distinct advantages of no surface scar and a lack of damage to the pump mechanism that often occur with external DCR. Recent evidence indicates a comparable success rate to external DCR.en_US
dc.languageengen_US
dc.relation.ispartofCurr Opin Ophthalmolen_US
dc.titleEvidence-based review of surgical practices in endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction and other new indicationsen_US
dc.typeArticleen_US
dc.identifier.emailMarcet, MM: marcet@hku.hken_US
dc.identifier.authorityMarcet, MM=rp01363en_US
dc.identifier.doi10.1097/icu.0000000000000084en_US
dc.identifier.pmid24979582-
dc.identifier.hkuros237844en_US
dc.identifier.volume25en_US
dc.identifier.issue5en_US
dc.identifier.spage443en_US
dc.identifier.epage8en_US
dc.identifier.isiWOS:000340564300013-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats